Companion Animals are primarily dogs, cats, but also horses. The Companion Animal segment (about 40% of market) is supported by rising pet ownership and pet spending, favorable reimbursement, and less stringent regulatory dynamics. The segment is poised for an influx of a number of new drugs over the next several years.
Production (livestock) is the larger (60%) and more mature segment of the Animal Health market, with cattle (beef and dairy), poultry, swine, sheep, and aquaculture (farmed fish) among others. Demand for affordable, safe protein is the key driver for the market. Emerging markets provide the largest opportunities
Anti-parasitic agents and vaccines remain the largest therapeutic categories in Animal Health followed by Anti-infectives, Medicated Feed Additives and “Other”. The Others category includes specialty drugs such as reproductive agents used in Production animals (especially cattle), osteoarthritis & pain medications, cancer agents, and medications for ailments such as allergy, dermatitis & arthritis. The “Other” segment is expected to drive the strongest growth as many new drugs (particularly on the Companion side) are expected to enter the market over the next few years as an increasing number of human drugs are adapted for animal use.
Once you register for a free online demo